Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy

Journal of the Peripheral Nervous System

Volumn 13, Issue 1, 2008, Pages 54-63

  Chi, Li Jun ^a   Wang, Hua Bing ^b   Wang, Wei Zhi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Auto immunity; CD4+CD25+ T regulatory cells (Tregs); Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP); FoxP3; Peripheral nerve

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CELLS, CULTURED; CHILD; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 40849116450     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2008.00158.x     Document Type: Article

References (43)

1. Allen D, Giannopoulos K, Gray I, Gregson N, Makowska A, Pritchard J, Hughes RA (2005). Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 10 : 174 180.
2. high regulatory cells in human peripheral blood. J Immunol 167 : 1245 1253.
3. Baecher-Allan C, Viglietta V, Hafler DA (2002). Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J Immunol 169 : 6210 6217.
4. Baecher-Allan C, Wolf E, Hafler DA (2005). Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells. Clin Immunol 115 : 10 18.
5. Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S (2004). Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood Online 105 : 735 741.
6. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR (1989). Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46 : 878 884.
7. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001). The immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEx) is caused by mutations of FOxP3. Nat Genet 27 : 20 21.
8. + T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33 : 215 223.
9. Chang X, Zheng P, Liu Y (2006). FoxP3: a genetic link between immunodeficiency and autoimmune diseases. Autoimmun Rev 5 : 399 402.
10. De Luca G, Lugaresi A, Iarlori C, Marzoli F, Di Iorio A, Gambi D, Uncini A (1999). Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 95 : 190 194.
11. + regulatory T cells. Nat Immunol 4 : 330 336.
12. Hayday A, Tigelaar R (2003). Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 3 : 233 242.
13. Hori S, Nomura T, Sakaguchi S (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299 : 1057 1061.
14. Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF (2005). Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 81 : 45 52.
15. Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T (2000). Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 164 : 4375 4381.
16. Joint Task Force of the EFNS and the PNS (2005). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10 : 220 228.
17. Karagiannidis C, Menz G, Akdis M, Holopainen P, Hense G, Rückert B, Mantel P-Y, Akdis CA, Blaser K (2004). Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114 : 1425 1433.
18. + T regulatory cells. Nat Immunol 4 : 337 342.
19. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, Boehmer VH (2005). Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6 : 1219 1227.
20. Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, Lorenz HM (2004). Defective suppressor function of human CD4+CD25+ regulatory T-cells in autoimmune polyglandular syndrome type II. J Exp Med 199 : 1285 1291.
21. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N (2002). Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109 : 131 140.
22. Liang S, Alard P, Zhao Y, Parnell S, Clark SL, Kosiewicz MM (2005). Conversion of CD4+CD25- cells into CD4+CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 201 : 127 137.
23. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TIM (2005). Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 54 : 92 99.
24. Liu MF, Wang CR, Fung LL, Wu CR (2004). Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59 : 198 202.
25. McHugh RS, Whitters MJ, Piccirillo CA (2002). CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16 : 311 323.
26. + regulatory T cells in patients with acute coronary syndromes. Eur Heart J 27 : 2530 2537.
27. Pollard JD (2002). Chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol 15 : 279 283.
28. Pritchard J, Makowska A, Gregson NA, Hayday AC, Hughe RA (2007). Reduced circulating CD4+CD25+ cell populations in Guillain-Barré syndrome. J Neuroimmunology 183 : 232 238.
29. Read S, Malmstrom V, Powrie F (2000). Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192 : 295 302.
30. Ryan MM, Grattan-Smith PJ, Procopis PG, Morgan G, Ouvrier RA (1996). Childhood chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord 6 : 311 325.
31. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T (2001). Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182 : 18 32.
32. Sakaguchi S (2004). Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immuno 22 : 531 562.
33. Sakaguchi S (2005). Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6 : 345 352.
34. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T (2006). FoxP3+CD25+CD4+ natural regulatory T cells in dominant selftolerance and autoimmune disease. Immunol Rev 212 : 8 27.
35. Setoguchi R, Hori S, Takahashi T, Sakaguchi S (2005). Homeostatic maintenance of natural Foxp3(+)CD25(+)CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201 : 723 735.
36. Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D (2000). Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci 21 : 31 37.
37. Van den Berg LH, Mollee I, Wokke JHJ, Logtenberg T (1995). Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barre′ syndrome and chronic inflammatory demyelinatingpoly neuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases. J Neuroimmunol 58 : 37 42.
38. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004). Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199 : 971 979.
39. Von Boehmer H (2005). Mechanisms of suppression by suppressor T cells. Nat Immunol 6 : 338 344.
40. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116 : 2423 2433.
41. Wildin RS, Ramsdell F, Peake J (2001). X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 : 18 20.
42. Wu Y, Wang HB, Wang WZ (2007). A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats. J Neuroimmunology 185 : 87 94.
43. + T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest 115 : 1361 1368.